Cartilage and Bone Serum Biomarkers as Novel Tools for Monitoring Knee Osteochondritis Dissecans Treated with Osteochondral Scaffold

Figure 4

Serum biomarkers evaluation in OCD patients at one-year follow-up and healthy subjects. Biomarkers of cartilage degradation (CTXII; C2C), synthesis (CPII), and bone remodeling (TRAP5b) at one-year treated (T2) OCD patients and healthy subjects. Data are expressed as mean ± SD. CTXII, C2C, CPII, and OC were expressed as ng/ml while TRAP5b as U/ml. Significant results are indicated.

(a)

(b)

(c)

(d)

(e)